CTV Toronto Highlights FSD Pharma’s Cobourg Facility
Ryan Allway
October 18th, 2018
News, Top News
Canada legalized recreational cannabis across the country this week, and created what could become a C$22.6 billion industry over the coming years. Canopy Growth Corp. (TSX: WEED) (NYSE: CGC), Aurora Cannabis Inc. (TSX: ACB) (OTC: ACBFF), and other ‘unicorns’ have captured a lot of attention, but they aren’t the only companies in the international limelight when it comes to covering the burgeoning cannabis industry.
FSD Pharma Inc. (CNSX: HUGE) (OTC: FSDDF) (FRA: 0K9) has continued to make rounds in the media with an appearance on CTV—Canada’s #1 television network for 17 consecutive years with 23 million weekly viewers. The news comes shortly after the company was featured on CNBC—a leading global financial broadcaster reaching millions of investors. These appearances reached both consumers and investors with captivating looks at its enormous potential.
The company’s renovated 70-acre Kraft facility could become the world’s largest hydroponic cannabis farm, located just an hour east of Toronto. With an existing 25,000 sq. ft. facility, the company has an annual production capacity of 4,000 kilograms. Management plans to dramatically expand its operations within the building’s 3.8 million sq. ft. footprint with plans to become the the largest indoor producer of marijuana in the world.
CTV Segment Reaches Key Markets
]
CTV’s recent segment focused on how legalization is giving new life for a former Kraft Foods Inc. (NYSE: KFT) factory. About ten years ago, the factory shut down and the small surrounding community lost around 1,300 jobs—which is significant for a population of just under 20,000 people. The plant had been operating since World War I before being acquired by General Foods (and eventually Kraft) back in 1989.
FSD Pharma acquired the facility, located just an hour from Toronto. The licensed facility has the potential for up to 3.8 million sq. ft.. Once the facility is completed the company forecasts 400,000,000 grams of marijuana production per year. The company is primarily focused on medical marijuana markets where the margins are most attractive and plans to hire more than 1,500 people over the long run, including R&D personnel, human resources, shipping and receiving, and other professionals.
Director Anthony Durkacz suggested that the facility could become an even bigger part of the town and country than it was as a Kraft facility, employing more people in higher paying jobs. Existing employees echoed these sentiments, saying that there has been a lot of interest in the surrounding community.
CNBC Segment Reaches Investors
FSD Pharma was also featured on CNBC—a leading financial broadcaster in the United States—earlier this month during its coverage of the upcoming Canadian cannabis market. Not surprisingly, cannabis has become a popular investment both in Canada and the United States. The industry has the potential to displace both the alcohol industry as a recreational option, as well as the opioid and pharmaceutical industry as a medicine.
The first of the four segments of CNBC’s coverage introduced the upcoming Canadian cannabis legalization milestone and featured a brief walkthrough of FSD Pharma’s facility. The second segment featured an interview with Director Anthony Durkacz. The third segment featured a further walkthrough of its facility in Ontario. And, the fourth segment featured an extended interview with Anthony on CNBC’s widely watched Power Lunch segment.
During one of the segments, Mr. Durkacz drew a comparison to the Internet bubble when asked if the cannabis industry was in a bubble, telling CNBC, “We are in a bubble — but we were in an internet bubble in 1998 that continued for another few years — if you did not make an investment in 1998, you missed a lion’s share of what could be earned in terms of return on investment.”
Looking Ahead
The coverage on both CTV and CNBC help bolster FSD Pharma Inc.’s (CSE: HUGE) ( OTCQB: FSDDF) (FRA: 0K9) credibility in the space with live footage of its facilities. In addition to raising its profile among investors, CTV’s coverage could reach millions of households in Toronto and potentially increase its consumer awareness at a key point in time.
The company could be a compelling investment opportunity in Canada’s burgeoning cannabis sector. In addition to its massive indoor facility, the company’s strategic investments and partnerships across the industry are paving the way for research, development, and distribution throughout the country and around the world.
For more information, visit the company’s website at www.fsdpharma.com.
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-discl
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Technical420 is the premier provider of research and analysis on cannabis stocks. We provide investors with sponsored and non-sponsored information on the volatile and emerging cannabis industry. “Our research is our passion!” Your profit is our reward!
Naturally Splendid is a biotechnology and consumer products company that is developing, producing, commercializing, and licensing an entirely new generation of plant-derived, bioactive ingredients, nutrient dense foods, and related products.
FSD Pharma is a publicly traded company on the Canadian Securities Exchange under the symbol HUGE. The Company, through its wholly-owned subsidiary FV Pharma Inc., holds an ACMPR license to cultivate cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR). HUGE, made history on its first day of trading on the Canadian Securities […]
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
